Traditionally, the treatment of type 2 diabetes has focused on blood glucose control and the prevention of complications. In the future, these therapeutic approaches could be complemented by another, which, according to current studies, could restore beta cell function and possibly lead to remission by targeting the reduction of glucotoxicity, lipotoxicity and insulin resistance.
Autoren
- Jens Dehn
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- Prostate cancer
Diagnosis without drama – ESMO 2025 under the banner of differentiated patient management
- Pneumococcal conjugate vaccine (PCV)
Best possible serotype coverage in the respective age group
- Psoriasis: intervening in the inflammatory cascade
Advantages of early biologic therapy and oral peptide as a beacon of hope
- AI-supported imaging and new biomarkers
CHD diagnostics update
- Bipolar disorder, anxiety disorder, depression
Lurasidone as monotherapy for bipolar I depression with anxiety symptoms
- Arterial hypertension: ESC guideline 2024 in focus
New category “elevated blood pressure” – what are the therapeutic implications?
- Palliative care symptom and needs assessment.
What screening tools are helpful?
- Low-grade pediatric gliomas